MLchartDataset catalogue

SNDX-275

Term · Oncology and biomedicine · MLC-T-ONC-007832

A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called entinostat and HDAC inhibitor SNDX-275.

Table 1. Record
IdentifierMLC-T-ONC-007832
FieldOncology and biomedicine
Expansionsentinostat; HDAC inhibitor SNDX-275
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007832",
  "term": "SNDX-275",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called entinostat and HDAC inhibitor SNDX-275.",
  "expansions": [
    "entinostat",
    "HDAC inhibitor SNDX-275"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sndx-275/"
}

Record 15,105 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.